Glucose Health Stock Working Capital
| GLUC Stock | USD 0.14 0.01 7.69% |
Glucose Health fundamentals help investors to digest information that contributes to Glucose Health's financial success or failures. It also enables traders to predict the movement of Glucose Pink Sheet. The fundamental analysis module provides a way to measure Glucose Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Glucose Health pink sheet.
Glucose |
Glucose Health Company Working Capital Analysis
Glucose Health's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Glucose Health Working Capital | (217 K) |
Most of Glucose Health's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Glucose Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
| Competition |
According to the company's disclosures, Glucose Health has a Working Capital of (217,000). This is 100.01% lower than that of the Consumer Defensive sector and 100.12% lower than that of the Packaged Foods industry. The working capital for all United States stocks is 100.01% higher than that of the company.
Glucose Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Glucose Health's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Glucose Health could also be used in its relative valuation, which is a method of valuing Glucose Health by comparing valuation metrics of similar companies.Glucose Health is currently under evaluation in working capital category among its peers.
Glucose Fundamentals
| Return On Equity | -0.5 | |||
| Return On Asset | -0.28 | |||
| Profit Margin | (0.32) % | |||
| Operating Margin | (0.32) % | |||
| Current Valuation | 1.16 M | |||
| Shares Outstanding | 4.55 M | |||
| Shares Owned By Insiders | 10.14 % | |||
| Shares Owned By Institutions | 0.25 % | |||
| Price To Earning | (1.99) X | |||
| Price To Sales | 3.42 X | |||
| Revenue | 1.11 M | |||
| Gross Profit | (2.41 K) | |||
| EBITDA | (336.06 K) | |||
| Net Income | (338.9 K) | |||
| Cash And Equivalents | 569.39 K | |||
| Cash Per Share | 0.04 X | |||
| Total Debt | 332.88 K | |||
| Current Ratio | 545.85 X | |||
| Book Value Per Share | 0.06 X | |||
| Cash Flow From Operations | (72.74 K) | |||
| Earnings Per Share | (0.04) X | |||
| Beta | 3.12 | |||
| Market Capitalization | 2.68 M | |||
| Total Asset | 207 K | |||
| Retained Earnings | (5.96 M) | |||
| Working Capital | (217 K) | |||
| Current Asset | 207 K | |||
| Current Liabilities | 424 K | |||
| Z Score | -33.9 |
About Glucose Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Glucose Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Glucose Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Glucose Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Glucose Pink Sheet
Glucose Health financial ratios help investors to determine whether Glucose Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Glucose with respect to the benefits of owning Glucose Health security.